Onconova Therapeutics Announces Presentations at the 15th International Symposium on Myelodysplastic Syndromes (MDS 2019) in Copenhagen, Denmark
May 06, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 06, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...
Geron Corporation Reports First Quarter 2019 Financial Results
May 02, 2019 16:17 ET
|
Geron Corporation
MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2019. As of the quarter-end, the Company...
Geron Expands Senior Leadership of Its Development Team
April 18, 2019 08:00 ET
|
Geron Corporation
MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced an expansion of its development team’s senior leadership with the addition of three highly...
Precipio’s HemeScreen™ Adopted by Methodist Health
April 03, 2019 07:38 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 03, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that Methodist Hospital, located in Memphis, TN, has selected...
Geron to Present at Needham Healthcare Conference
April 02, 2019 16:30 ET
|
Geron Corporation
MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to present a...
Onconova Therapeutics to Present Update at the 2019 HCW Global Life Sciences Conference in London, April 7-9
April 02, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Geron Appoints Two New Independent Board Members
March 28, 2019 08:00 ET
|
Geron Corporation
MENLO PARK, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the appointments of Dawn C. Bir and Elizabeth G. O’Farrell as independent members of its Board...
Onconova Therapeutics, Inc. Reports Business Highlights and Full Year 2018 Financial Results
March 26, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., March 26, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...
Onconova Achieves Over 75 Percent of Planned Enrollment in Pivotal Phase 3 INSPIRE Study of Rigosertib in Myelodysplastic Syndromes
March 25, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
Full enrollment of 360 patients anticipated in second half of 2019Pivotal global study continues enrolling worldwide Potential for first new therapy in 15 years to address unmet medical need in MDS ...
Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2018 Financial Results
March 19, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., March 19, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...